Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Prescribed List (Jersey) - changes with effect from 1 October 2010

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made 6 August 2010 regarding: Prescribed List (Jersey) - changes with effect from 1 October 2010.

Decision Reference: MD-S-2010-0041

Decision Summary Title :

Prescribed List (Jersey)  1 October 2010

Date of Decision Summary:

27 July 2010

Decision Summary Author:

Business Manager

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

N/A

Written Report

Title :

Changes to be made to the Prescribed List (Jersey) as at 1 October 2010

Date of Written Report:

13 July 2010

Written Report Author:

Prescribing Adviser

Written Report :

Public or Exempt?

Public

Subject:

Changes to be made to the Prescribed List (Jersey) with effect from 1 October 2010

Decision(s):

The Minister approved amendments to the Prescribed List under Article 15 (11) (a) of the Health Insurance (Jersey) Law 1967 with effect from 1 October 2010. The changes are detailed as follows in the accompanying report: 

Table 1 - Items to be included from 1 October 2010

Table 2 – Items to be amended from 1 October 2010

Reason(s) for Decision:

The Pharmaceutical Benefit Advisory Committee met on 13 July 2010 and provided the Minister with the recommended changes to the Prescribed List (Jersey), effective from 1 October 2010. The changes reflect current evidence and expert advice, and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs.

Resource Implications:

The recommended changes represent an estimated additional cost to the fund of around £500.00 per annum.

Action required:

Business Manager to issue a public notice listing amendments and notify all approved medical practitioners and approved contractors.

Signature: 

Position:

Minister

Date Signed: 

Date of Decision (If different from Date Signed): 

Prescribed List (Jersey) - changes with effect from 1 October 2010

RECOMMENDATIONS OF THE

PHARMACEUTICAL BENEFIT ADVISORY COMMITTEE  

13 JULY 2010  

1. Summary  

The Pharmaceutical benefit Advisory Committee (PBAC) met on 13 July 2010 to consider applications for changes to the Prescribed List. Further to this meeting the changes detailed in the following tables have been approved by the Social Security Minister. 
 

2.      Summary tables with estimated annual costs

 

Table 1: New products to be added to the Prescribed List  

Item

 
 
Reason for change

Estimated net effect on annual expenditure

2.1.1 Triclosan solution 1% - open order

To replace 2% solution, which is unavailable

No change

2.1.2 Bimatoprost 100mcg/mL eye drops – open order

Lower strength alternative to product already on the Prescribed List

£500

2.1.3 Carmellose sodium 0.5%/glycerol eye drops (Optive) – open order

Product has longer shelf-life after opening (6 months) compared to other options (28 days)

No change

2.1.4 Tafluprost unit dose eye drops 15mcg/mL (Saflutan) – open order

Preservative free alternative to other products in this class of treatments

No change

 

      Table 2: Other amendments to the Prescribed List 

2.2.1Maxolon brand name to be deleted and entry modified to read: metoclopramide oral solution (sugar free) 5mg/5mL – generic only

Brand no longer available

No change

2.2.2 Metoclopramide oral solution (sugar free) 5mg/5mL to be made generic only

Brand no longer available

No change

2.2.3 Metoclopramide paediatric solution to be removed from Prescribed List

Product no longer available

No change


 

 

Back to top
rating button